MUMBAI, December 13, 2013 /PRNewswire/ --
Bharat Book Bureau presents Molecular Diagnostics Markets. In this report The technologies that constitute molecular diagnostics--like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and micro fluidics, next-generation signal detection, biosensors, and molecular labels--are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments. (http://www.bharatbook.com/healthcare-market-research-reports/molecular-diagnostics-markets.html)
This report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctor's offices. Diagnostic tests marketed primarily as over-the-counter are generally not included in this report, although there is inevitably some overlap.
The main objectives of this analysis are:
|SOURCE Bharat Book Bureau|
Copyright©2012 PR Newswire.
All rights reserved